Beneficient Financials

Beneficient (BENF) reported $40K in total revenue for fiscal year 2026. This represents a -9.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Beneficient (BENF) revenue declined by 9.1% year-over-year, from $44K to $40K in fiscal year 2026.

No, Beneficient (BENF) reported a net income of -$87.4M in fiscal year 2026, with a net profit margin of -218565.0%.

Beneficient (BENF) had EBITDA of -$165.8M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

Beneficient (BENF) had an operating margin of -416280.0% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

Beneficient (BENF) had a net profit margin of -218565.0% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

Beneficient (BENF) generated -$38.8M in free cash flow during fiscal year 2026. This represents a -0.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Beneficient (BENF) generated -$38.7M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

Beneficient (BENF) had $238.8M in total assets as of fiscal year 2026, including both current and long-term assets.

Beneficient (BENF) invested $96K in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

Beneficient (BENF) had a debt-to-equity ratio of -2.26 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

Beneficient (BENF) had a return on assets of -36.6% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2026 data, Beneficient (BENF) had $2.5M in cash against an annual operating cash burn of $38.7M. This gives an estimated cash runway of approximately 1 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Beneficient (BENF) has negative shareholder equity of -$189.3M as of fiscal year 2026, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Beneficient (BENF) has a Piotroski F-Score of 2 out of 5 computable signals; 4 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Beneficient (BENF) has an earnings quality ratio of 0.44x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Beneficient (BENF) has an interest coverage ratio of -8.9x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.